Latest News and Press Releases
Want to stay updated on the latest news?
-
HBC had gross operating revenues of NOK 69.3m (67.8m) in 2020 and operating revenues of NOK 23.1m (11.1m) in the fourth quarter. Cost of Goods Sold (CoGS) amounted to NOK 16.7m (16.6m) in the quarter...
-
Achilles Therapeutics Announces Independent Data and Safety Monitoring Committee Review with a Positive Recommendation to Continue with Current Study Design of the Phase I/IIa CHIRON and THETIS Trials...
-
5 February 2021 Alliance Trust PLC TRANSACTION IN OWN SHARES The Board of Alliance Trust PLC ("the Company") announces that on 4 February 2021 the Company purchased for cancellation 230,000...
-
Australia, a world-renowned surgical robotics market, introduces first Versius system ·Australia becomes the fifth global market to introduce Versius, following approval from the Therapeutic...
-
NEW YORK and LONDON, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics...
-
New York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “5G Fixed Wireless Access (FWA) Market By Offering (Hardware And Services), By Frequency...
-
Press release Interim Report 1 April–31 December 2020 Third quarter (1 October–31 December 2020) Revenue increased by 11 percent to MSEK 1,086 (976).EBITA increased by 84 percent to MSEK 68...
-
Rueil Malmaison, 5 February 2021 2020 ANNUAL RESULTS Significant fall in earnings in the context of an unprecedented health crisisVery high free cash flow: €4.0 billion, close to the record 2019...
-
CONSTI PLC FINANCIAL STATEMENTS BULLETIN 5 FEBRUARY 2021, at 8.30 a.m. Consti Plc Financial Statements Bulletin for January – December 2020 PROFITABILITY CONTINUED TO IMPROVE ...
-
Q4 2020 sales growth(2) of 4.2% and business EPS growth of 9.8% at CER Specialty Care sales grew 18.3%, driven by strong Dupixent® performance (+54.2% to €982 million).Vaccines up 14.6%, driven by...